Egalet Corporation Company Profile (NASDAQ:EGLT)

About Egalet Corporation (NASDAQ:EGLT)

Egalet Corporation logoEgalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company's products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company's product SPRIX Nasal Spray, which contains ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. The Company's product OXAYDO is an approved immediate-release (IR) oxycodone product formulated to deter abuse through snorting. The Company's product candidate, ARYMO ER is an abuse-deterrent (AD), extended-release (ER), oral morphine formulation. The Company's product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:EGLT
  • CUSIP: N/A
  • Web:
  • Market Cap: $28.1 million
  • Outstanding Shares: 43,048,000
Average Prices:
  • 50 Day Moving Avg: $1.30
  • 200 Day Moving Avg: $2.23
  • 52 Week Range: $1.01 - $10.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.93
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $22.53 million
  • Price / Sales: 2.04
  • Book Value: ($1.48) per share
  • Price / Book: -0.72
  • EBITDA: ($79,770,000.00)
  • Net Margins: -444.50%
  • Return on Equity: -607.49%
  • Return on Assets: -79.76%
  • Debt-to-Equity Ratio: -3.22%
  • Current Ratio: 3.11%
  • Quick Ratio: 3.04%
  • Average Volume: 436,427 shs.
  • Beta: 0.31
  • Short Ratio: 4.61

Frequently Asked Questions for Egalet Corporation (NASDAQ:EGLT)

What is Egalet Corporation's stock symbol?

Egalet Corporation trades on the NASDAQ under the ticker symbol "EGLT."

How were Egalet Corporation's earnings last quarter?

Egalet Corporation (NASDAQ:EGLT) posted its quarterly earnings data on Wednesday, August, 9th. The company reported ($1.04) earnings per share for the quarter, missing the consensus estimate of ($0.94) by $0.10. The business earned $6.26 million during the quarter, compared to the consensus estimate of $6.68 million. Egalet Corporation had a negative net margin of 444.50% and a negative return on equity of 607.49%. The firm's revenue was up 81.4% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.97) earnings per share. View Egalet Corporation's Earnings History.

When will Egalet Corporation make its next earnings announcement?

Egalet Corporation is scheduled to release their next quarterly earnings announcement on Friday, November, 3rd 2017. View Earnings Estimates for Egalet Corporation.

Where is Egalet Corporation's stock going? Where will Egalet Corporation's stock price be in 2017?

5 brokers have issued 1 year price objectives for Egalet Corporation's stock. Their predictions range from $6.00 to $9.50. On average, they anticipate Egalet Corporation's stock price to reach $7.10 in the next year. View Analyst Ratings for Egalet Corporation.

Who are some of Egalet Corporation's key competitors?

Who are Egalet Corporation's key executives?

Egalet Corporation's management team includes the folowing people:

  • Timothy P. Walbert, Independent Chairman of the Board
  • Robert Radie, President, Chief Executive Officer, Director
  • Stanley J. Musial, Chief Financial Officer, Executive Vice President, Secretary
  • Mark Strobeck Ph.D., Chief Operating Officer, Executive Vice President
  • Paul C. Varki J.D., Senior Vice President, General Counsel
  • E. Blair Clark-Schoeb, Senior Vice President - Communications
  • Karsten Lindhardt Ph.D., Senior Vice President - Research & Development
  • Barbara Carlin, Chief Accounting Officer
  • Jeffrey M. Dayno M.D., Chief Medical Officer
  • Patrick M. Shea, Chief Commercial Officer

How do I buy Egalet Corporation stock?

Shares of Egalet Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Egalet Corporation's stock price today?

One share of Egalet Corporation stock can currently be purchased for approximately $1.07.

MarketBeat Community Rating for Egalet Corporation (NASDAQ EGLT)
Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  86 (Vote Underperform)
Total Votes:  290
MarketBeat's community ratings are surveys of what our community members think about Egalet Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Egalet Corporation (NASDAQ:EGLT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.10 (563.55% upside)
Consensus Price Target History for Egalet Corporation (NASDAQ:EGLT)
Price Target History for Egalet Corporation (NASDAQ:EGLT)
Analysts' Ratings History for Egalet Corporation (NASDAQ:EGLT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/26/2017Cantor FitzgeraldReiterated RatingBuyLowView Rating Details
8/14/2017GuggenheimSet Price TargetBuy$7.00HighView Rating Details
8/10/2017Stifel NicolausReiterated RatingBuy -> Buy$14.00 -> $6.00HighView Rating Details
7/14/2017JMP SecuritiesLower Price TargetMarket Outperform$15.00 -> $6.00MediumView Rating Details
5/12/2017GabelliUpgradeHold -> Buy$9.50HighView Rating Details
3/14/2016Janney Montgomery ScottInitiated CoverageNeutral$8.00N/AView Rating Details
(Data available from 10/18/2015 forward)


Earnings History for Egalet Corporation (NASDAQ:EGLT)
Earnings by Quarter for Egalet Corporation (NASDAQ:EGLT)
Earnings History by Quarter for Egalet Corporation (NASDAQ EGLT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2017Q2 2017($0.94)($1.04)$6.68 million$6.26 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.90)($1.02)$6.92 million$5.57 millionViewN/AView Earnings Details
3/9/2017Q4 2016($0.92)($0.87)$5.37 million$6.14 millionViewListenView Earnings Details
11/4/2016Q316($0.90)($1.10)$4.50 million$4.70 millionViewN/AView Earnings Details
8/4/2016Q216($0.82)($0.97)$3.83 million$3.45 millionViewN/AView Earnings Details
5/10/2016Q116($0.87)($0.76)$3.50 million$2.70 millionViewListenView Earnings Details
3/8/2016Q415($0.91)($0.28)$2.80 million$2.10 millionViewN/AView Earnings Details
11/4/2015Q315($0.90)($0.81)$1.62 million$1.30 millionViewN/AView Earnings Details
8/6/2015Q215($1.02)($0.98)$0.95 million$0.96 millionViewN/AView Earnings Details
5/7/2015Q1 2015($0.98)($1.02)$3.00 million$0.81 millionViewN/AView Earnings Details
3/16/2015Q414($0.71)($0.52)$0.30 million$0.83 millionViewN/AView Earnings Details
11/12/2014Q314($0.75)($0.63)$0.35 millionViewN/AView Earnings Details
8/12/2014Q214($0.41)($0.73)$0.49 millionViewN/AView Earnings Details
5/13/2014Q114($0.16)($1.34)$0.26 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Egalet Corporation (NASDAQ:EGLT)
Current Year EPS Consensus Estimate: $-2.75 EPS
Next Year EPS Consensus Estimate: $-1.15 EPS


Dividend History for Egalet Corporation (NASDAQ:EGLT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Egalet Corporation (NASDAQ:EGLT)
Insider Ownership Percentage: 3.80%
Institutional Ownership Percentage: 32.61%
Insider Trades by Quarter for Egalet Corporation (NASDAQ:EGLT)
Institutional Ownership by Quarter for Egalet Corporation (NASDAQ:EGLT)
Insider Trades by Quarter for Egalet Corporation (NASDAQ:EGLT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2017Mark StrobeckCOOSell8,700$1.29$11,223.00View SEC Filing  
10/2/2017Patrick M SheaInsiderSell910$1.30$1,183.00View SEC Filing  
7/3/2017Patrick M. SheaInsiderSell910$2.35$2,138.50View SEC Filing  
7/3/2017Paul VarkiSVPSell806$2.35$1,894.10View SEC Filing  
7/3/2017Stan MusialCFOSell3,480$2.36$8,212.80View SEC Filing  
6/30/2017Mark StrobeckCOOSell8,700$2.39$20,793.00View SEC Filing  
4/3/2017Paul VarkiSVPSell806$5.05$4,070.30View SEC Filing  
4/3/2017Stan MusialCFOSell8,613$5.04$43,409.52View SEC Filing  
3/31/2017Jeffrey M DaynoInsiderSell536$5.16$2,765.76View SEC Filing  
3/31/2017Mark StrobeckCOOSell8,700$5.11$44,457.00View SEC Filing  
3/20/2017Patrick M SheaInsiderSell4,250$4.75$20,187.50View SEC Filing  
1/3/2017Jeffrey M DaynoInsiderSell536$7.75$4,154.00View SEC Filing  
1/3/2017Paul VarkiSVPSell806$7.75$6,246.50View SEC Filing  
1/3/2017Stan MusialCFOSell13,480$7.73$104,200.40View SEC Filing  
12/30/2016Mark StrobeckCOOSell8,700$7.81$67,947.00View SEC Filing  
10/3/2016Paul VarkiSVPSell806$7.56$6,093.36View SEC Filing  
10/3/2016Robert S RadieInsiderSell15,000$7.47$112,050.00View SEC Filing  
10/3/2016Stan MusialCFOSell13,480$7.47$100,695.60View SEC Filing  
9/30/2016Jeffrey M DaynoInsiderSell536$7.69$4,121.84View SEC Filing  
9/30/2016Mark StrobeckCOOSell33,700$7.58$255,446.00View SEC Filing  
7/6/2016Robert S RadieCEOSell15,000$5.01$75,150.00View SEC Filing  
7/5/2016Robert S RadieCEOSell5,000$4.94$24,700.00View SEC Filing  
7/5/2016Stan MusialCFOSell13,480$5.06$68,208.80View SEC Filing  
7/1/2016Robert S RadieCEOSell5,000$5.07$25,350.00View SEC Filing  
7/1/2016Stan MusialCFOSell10,000$5.06$50,600.00View SEC Filing  
6/30/2016Jeffrey M DaynoInsiderSell536$4.65$2,492.40View SEC Filing  
4/5/2016Deanne F MelloyInsiderSell860$6.96$5,985.60View SEC Filing  
4/5/2016Robert S RadieCEOSell5,000$6.99$34,950.00View SEC Filing  
4/4/2016Robert S RadieCEOSell10,000$6.97$69,700.00View SEC Filing  
1/11/2016Robert S. RadieCEOSell10,000$9.65$96,500.00View SEC Filing  
1/6/2016Robert S. RadieCEOSell5,000$10.52$52,600.00View SEC Filing  
10/6/2015Deanne F MelloyInsiderSell860$11.42$9,821.20View SEC Filing  
10/1/2015Robert S RadieCEOSell15,000$12.27$184,050.00View SEC Filing  
10/1/2015Stan MusialCFOSell8,480$12.32$104,473.60View SEC Filing  
9/30/2015Mark StrobeckInsiderSell5,220$12.56$65,563.20View SEC Filing  
7/8/2015Robert S RadieCEOSell6,000$11.97$71,820.00View SEC Filing  
7/6/2015Robert S RadieCEOSell9,000$12.53$112,770.00View SEC Filing  
7/1/2015Mark StrobeckInsiderSell10,440$12.98$135,511.20View SEC Filing  
7/1/2015Stan MusialCFOSell8,480$13.20$111,936.00View SEC Filing  
4/1/2015Robert S RadieCEOSell11,130$11.25$125,212.50View SEC Filing  
2/3/2015Jeffrey M DaynoInsiderSell2,500$8.87$22,175.00View SEC Filing  
1/2/2015Mark StrobeckInsiderSell3,480$5.09$17,713.20View SEC Filing  
1/2/2015Robert S RadieCEOSell11,130$5.11$56,874.30View SEC Filing  
9/10/2014Robert S RadieCEOSell40,040$9.61$384,784.40View SEC Filing  
9/8/2014Robert S RadieCEOSell49,000$9.74$477,260.00View SEC Filing  
8/13/2014Mark StrobeckInsiderSell5,135$9.20$47,242.00View SEC Filing  
8/11/2014Mark StrobeckInsiderSell5,700$10.28$58,596.00View SEC Filing  
8/7/2014Mark StrobeckInsiderSell3,085$11.50$35,477.50View SEC Filing  
8/7/2014Stan MusialCFOSell13,920$11.05$153,816.00View SEC Filing  
2/11/2014Jean Francois FormelaDirectorBuy41,667$12.00$500,004.00View SEC Filing  
2/11/2014Life Science Ventures SunstoneMajor ShareholderBuy133,333$12.00$1,599,996.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Egalet Corporation (NASDAQ:EGLT)
Latest Headlines for Egalet Corporation (NASDAQ:EGLT)
DateHeadline logoETFs with exposure to Egalet Corp. : October 9, 2017 - October 9 at 6:34 PM logoEgalet Corporation (EGLT) Receives Consensus Rating of "Buy" from Brokerages - October 8 at 5:18 AM logoEgalet Corp. :EGLT-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 - October 6 at 6:34 PM logoEgalet Corporation (EGLT) COO Sells $11,223.00 in Stock - October 3 at 11:56 PM logoHead-To-Head Comparison: Egalet Corporation (EGLT) versus Its Peers - September 30 at 10:20 PM logoNational Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management - September 18 at 6:04 PM logoStocks Under Scanner in the Biotech Space -- Curis, Egalet, and Esperion Therapeutics - September 13 at 7:33 PM logoEgalet Corporation (EGLT) Given Consensus Rating of "Buy" by Brokerages - September 13 at 5:06 AM logoEgalet (EGLT) Announced New Data at PAINWEEK Demonstrating ... - - September 8 at 11:41 PM logoEgalet (EGLT) Announced New Data at PAINWEEK Demonstrating Potential of ARYMO ER to Deter Opioid Abuse - September 8 at 6:39 PM logoEgalet Presented New Data at PAINWEEK Demonstrating Potential of ARYMO ER to Deter Opioid Abuse - September 8 at 6:39 PM logoEgalet to Present at Investor Conferences this Fall - September 6 at 6:07 PM logoSpark Therapeutics (ONCE) & Egalet Corporation (EGLT) Financial Analysis - September 6 at 8:38 AM logoEgalet's partner Ascend Therapeutics begins promotion of SPRIX nasal spray - September 5 at 7:50 PM logoEgalet's Partner Ascend Therapeutics® U.S., LLC Begins Promotion of SPRIX® Nasal Spray - September 5 at 7:50 PM logoEgalet (EGLT) Announces PAINWeek Scientific Presentations - - August 29 at 6:36 PM logoEgalet Announces Scientific Presentations at PAINWeek 2017 Meeting - August 29 at 6:36 PM logoEgalet Corporation's (EGLT) "Buy" Rating Reiterated at Cantor Fitzgerald - August 26 at 11:02 AM logoEgalet Corporation Expected to Earn FY2017 Earnings of ($2.84) Per Share (EGLT) - August 23 at 8:38 AM logoCantor Fitzgerald Reaffirms Overweight Rating for Egalet Corporation (EGLT) - August 23 at 8:36 AM logoEgalet Corporation (EGLT) Receives Average Rating of "Buy" from Analysts - August 19 at 4:36 AM logoEgalet Corporation (EGLT) Stock Rating Reaffirmed by Cantor Fitzgerald - August 14 at 3:34 PM logoEgalet Corporation (NASDAQ:EGLT) Announces Earnings Results, Misses Expectations By $0.10 EPS - August 11 at 3:00 PM logoEdited Transcript of EGLT earnings conference call or presentation 9-Aug-17 8:30pm GMT - August 11 at 12:31 AM logoEgalet's (EGLT) CEO Bob Radie on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha - August 9 at 11:24 PM logoEgalet trims non-sales workforce by 40% - Philadelphia Business Journal - August 9 at 6:23 PM logoInvestor Network: Egalet Corporation to Host Earnings Call - August 9 at 6:22 PM logoEgalet Announces Second Quarter 2017 Financial Results and Expense Reduction Plan - August 9 at 6:22 PM logoEgalet reports 2Q loss - August 9 at 6:22 PM logoEgalet trims non-sales workforce by 40% - August 9 at 6:22 PM logoEgalet Corporation (EGLT) to Release Earnings on Wednesday - August 2 at 7:26 AM logoEgalet's Guardian Technology Begins Fight Against Opioid Abuse Epidemic - August 1 at 6:51 PM logoShort Interest in Egalet Corporation (NASDAQ:EGLT) Decreases By 34.8% - July 28 at 2:21 AM logoEgalet to Host Conference Call and Webcast on August 9, 2017 to Discuss Second Quarter 2017 Financial Results - July 26 at 6:45 PM logoEgalet Corporation (NASDAQ:EGLT) Given Consensus Recommendation of "Buy" by Analysts - July 25 at 10:27 AM logoFY2017 EPS Estimates for Egalet Corporation Raised by Gabelli (EGLT) - July 19 at 12:21 PM logoEgalet Corporation (NASDAQ:EGLT) PT Lowered to $6.00 - July 14 at 12:33 PM logoEgalet Announces Closing of $30 Million Public Equity Offering - PR Newswire (press release) - July 11 at 7:20 PM logoEgalet Announces Closing of $30 Million Public Equity Offering - July 11 at 7:20 PM logoMid-Day Market Update: Crude Oil Up Over 2%; Egalet Shares Plummet - July 6 at 7:29 PM logoEgalet's stock plunges toward record low after stock offering plan - July 6 at 7:29 PM logoEgalet Announces Pricing of Public Offering of Common Stock and Warrants - July 6 at 7:29 PM logoEgalet (EGLT) Announces Public Offering - July 6 at 2:26 AM logoMark Strobeck Sells 8,700 Shares of Egalet Corporation (EGLT) Stock - July 5 at 8:32 PM logoAfter-Hours Movers 07/05: (MLHR) (ZUMZ) Higher; (EGLT) (PSMT) (YUMC) Lower (more...) - July 5 at 6:52 PM logoEgalet Corp. (EGLT) Is Down After Offering Announcement - July 5 at 6:52 PM logoEgalet Announces Proposed Public Offering of Common Stock and Warrants - July 5 at 6:52 PM logoEgalet Corporation (EGLT) Presents At JMP Securities Life Sciences Conference 2017 - Slideshow - June 23 at 7:24 AM logoEgalet Stumbles Over FDA Complete Response Letter - 24/7 Wall St. - June 20 at 5:38 PM logoEgalet partners with Ascend Therapeutics to co-promote SPRIX nasal spray - June 8 at 2:38 AM



Egalet Corporation (EGLT) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.